Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

SCPH holding history

scPharmaceuticals Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SCPH overviewAll 13F holders of SCPHFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of SCPH by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−892,301−100.0%Sold outHolders
Q3 2025892,301$5.06M<0.1%+142,817+19.1%AddedHolders
Q2 2025749,484$2.86M<0.1%−57,996−7.2%ReducedHolders
Q1 2025807,480$2.12M<0.1%+56,987+7.6%AddedHolders
Q4 2024750,493$2.66M<0.1%+107,151+16.7%AddedHolders
Q3 2024643,342$2.93M<0.1%+61,582+10.6%AddedHolders
Q2 2024581,760$2.53M<0.1%+39,917+7.4%AddedHolders
Q1 2024541,843$2.72M<0.1%+4,095+0.8%AddedHolders
Q4 2023537,748$3.37M<0.1%+25,927+5.1%AddedHolders
Q3 2023511,821$3.64M<0.1%+66,107+14.8%AddedHolders
Q2 2023445,714$4.54M<0.1%+274,270+160.0%AddedHolders
Q1 2023171,444$1.55M<0.1%+74,523+76.9%AddedHolders
Q4 202296,921$694.0K<0.1%+11,736+13.8%AddedHolders
Q3 202285,185$555.0K<0.1%+6,611+8.4%AddedHolders
Q2 202278,574$378.0K<0.1%+9,322+13.5%AddedHolders
Q1 202269,252$393.0K<0.1%−1,957−2.7%ReducedHolders
Q4 202171,209$357.0K<0.1%−140.0%ReducedHolders
Q3 202171,223$473.0K<0.1%+4,748+7.1%AddedHolders
Q2 202166,475$406.0K<0.1%−31,605−32.2%ReducedHolders
Q1 202198,080$652.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.